Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 1
2004 1
2005 2
2007 2
2011 1
2012 1
2013 1
2015 3
2016 3
2017 3
2018 5
2019 3
2020 4
2021 6
2022 4
2023 1
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.
Selexipag for the Treatment of Pulmonary Arterial Hypertension.
Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV; GRIPHON Investigators. Sitbon O, et al. N Engl J Med. 2015 Dec 24;373(26):2522-33. doi: 10.1056/NEJMoa1503184. N Engl J Med. 2015. PMID: 26699168 Free article. Clinical Trial.
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators. Galiè N, et al. N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687. N Engl J Med. 2015. PMID: 26308684 Free article. Clinical Trial.
[Idiopathic pulmonary fibrosis: new insights].
Kraan JW, van den Blink B, van den Toorn LM, Bresser P, van Beek FT, Grutters JC, Wijsenbeek MS. Kraan JW, et al. Among authors: van den toorn lm. Ned Tijdschr Geneeskd. 2015;159:A8148. Ned Tijdschr Geneeskd. 2015. PMID: 25654681 Review. Dutch.
The pressure mounts on lung dendritic cells.
Lambrecht BN, van den Toorn LM. Lambrecht BN, et al. Among authors: van den toorn lm. Eur Respir J. 2007 Mar;29(3):435-7. doi: 10.1183/09031936.00002507. Eur Respir J. 2007. PMID: 17329489 Free article. No abstract available.
Asthma remission: does it exist?
van den Toorn LM, Overbeek SE, Prins JB, Hoogsteden HC, de Jongste JC. van den Toorn LM, et al. Curr Opin Pulm Med. 2003 Jan;9(1):15-20. doi: 10.1097/00063198-200301000-00003. Curr Opin Pulm Med. 2003. PMID: 12476079 Review.
Integrated care pathway for occupational pulmonary diseases.
van der Valk JPMH, den Besten LAAH, Hylkema THT, van der Zee JSJ, Nijman SFMS, Van den Toorn LML, Braunstahl GJG, In 't Veen JCCMJ, van Balen PP, Maas JJJ, Wennekes RHAR, de Groene GJG, Kappen JHJ. van der Valk JPMH, et al. Among authors: van den toorn lml. Allergy. 2024 Nov;79(11):3138-3141. doi: 10.1111/all.16200. Epub 2024 Jun 28. Allergy. 2024. PMID: 38940064 No abstract available.
44 results